Deirdre Weymann (Dean Regier, Dean A Regier)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Venues

Health expectations : an international journal of public participation in health care and health policy

Journal of community genetics

Health affairs scholar

European journal of human genetics : EJHG

BC Cancer

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BC Cancer Nov 11 2015

Canada

Scientist :: Cancer Control Research, BC Cancer Research Centre

Publications

Deborah A Marshall, Nicolle Hua, James Buchanan, Kurt D Christensen, Geert W J Frederix, Ilias Goranitis, Maarten J IJzerman, Jeroen P Jansen, Tara A Lavelle, Deirdre Weymann, Hadley Stevens Smith, Wendy J Ungar, Deirdre Weymann, Sarah Wordsworth, Kathryn A Phillips
Paving the path for implementation of clinical genomic sequencing globally: Are we ready? Health affairs scholar 2 (5) (2024)
Samantha Pollard, Morgan Ehman, Anna Hermansen, Deirdre Weymann, Emanuel Krebs, Cheryl Ho, Howard J Lim, Steven J M Jones, Yvonne Bombard, Timothy P Hanna, Chiquita Hessels, Holly Longstaff, Robert M Cook-Deegan, Tania Bubela, Deirdre Weymann
"I Just Assumed This Was Already Being Done": Canadian Patient Preferences for Enhanced Data Sharing for Precision Oncology. JCO precision oncology 8 (2024)
Deborah A Marshall, Nicolle Hua, James Buchanan, Kurt D Christensen, Geert W J Frederix, Ilias Goranitis, Maarten J IJzerman, Jeroen P Jansen, Tara A Lavelle, Deirdre Weymann, Hadley Stevens Smith, Wendy J Ungar, Deirdre Weymann, Sarah Wordsworth, Kathryn A Phillips
Paving the path for implementation of clinical genomic sequencing globally: Are we ready? Health affairs scholar 2 (5) (2024)
Deirdre Weymann, Emanuel Krebs, Deirdre Weymann
Addressing immortal time bias in precision medicine: Practical guidance and methods development. Health services research (2024)
Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A Schrader, Chiquita Hessels, Deirdre Weymann
Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach. Health expectations : an international journal of public participation in health care and health policy (2023)
Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A Schrader, Chiquita Hessels, Deirdre Weymann
Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach. Health expectations : an international journal of public participation in health care and health policy 26 (2) (2023)
Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A Schrader, Chiquita Hessels, Deirdre Weymann
Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach. Health expectations : an international journal of public participation in health care and health policy 26 (2) (2023)
Reka E Pataky, Stirling Bryan, J Mark FitzGerald, Stuart J Peacock, Deirdre Weymann
Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada. PharmacoEconomics - open (2023)
Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A Schrader, Chiquita Hessels, Deirdre Weymann
Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach. Health expectations : an international journal of public participation in health care and health policy 26 (2) (2023)
Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A Schrader, Chiquita Hessels, Deirdre Weymann
Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach. Health expectations : an international journal of public participation in health care and health policy 26 (2) (2023)
Ella Adi-Wauran, Marc Clausen, Salma Shickh, Anna R Gagliardi, Avram Denburg, Leslie E Oldfield, Jordan Sam, Emma Reble, Suvetha Krishnapillai, Deirdre Weymann, Nancy N Baxter, Lesa Dawson, Lynette S Penney, William D Foulkes, Mark Basik, Sophie Sun, Kasmintan A Schrader, Aly Karsan, Aaron Pollett, Trevor J Pugh, null null, Raymond H Kim, Yvonne Bombard
"I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening. European journal of human genetics : EJHG (2023)
Anna Hermansen, Deirdre Weymann, Samantha Pollard
Developing Data Sharing Models for Health Research with Real-World Data: A Scoping Review of Patient and Public Preferences. Journal of medical systems 46 (12) (2022)
Deirdre Weymann, Samantha Pollard, Melanie McPhail, Tania Bubela, Timothy P Hanna, Cheryl Ho, Howard J Lim, Kelvin Chan, Stuart J Peacock, Deirdre Weymann
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada. NPJ precision oncology 6 (1) (2022)
Reka E Pataky, Stirling Bryan, J Mark FitzGerald, Stuart J Peacock, Deirdre Weymann
Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions. PharmacoEconomics 40 (10) (2022)
Cheryl Ho, Brandon Chan, David Cameron, Aria Shokoohi, Deirdre Weymann, Howard J Lim
Readiness of Healthcare Systems to Generate Real-World Evidence: Reliability of CT Radiographic End Points for Evaluation of First-Line Systemic Treatment. JCO oncology practice 17 (12) (2021)
Samantha Pollard, Deirdre Weymann, Jessica Dunne, Fatemeh Mayanloo, John Buckell, James Buchanan, Sarah Wordsworth, Jan M Friedman, Sylvia Stockler-Ipsiroglu, Nick Dragojlovic, Alison M Elliott, Mark Harrison, Larry D Lynd, Deirdre Weymann
Toward the diagnosis of rare childhood genetic diseases: what do parents value most? European journal of human genetics : EJHG 29 (10) (2021)
Deirdre Weymann, Janessa Laskin, Steven J M Jones, Robyn Roscoe, Howard J Lim, Daniel J Renouf, Kasmintan A Schrader, Sophie Sun, Stephen Yip, Marco A Marra, Deirdre Weymann
Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care. Journal of community genetics (2021)
Shan Jiang, Aslam H Anis, Ian Cromwell, Tima Mohammadi, Kasmintan A Schrader, Janet Lucas, Christine M Armour, Marc Clausen, Yvonne Bombard, Deirdre Weymann
Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment. Genetics in medicine : official journal of the American College of Medical Genetics 22 (12) (2020)
Nathaniel Hendrix, Deirdre Weymann, Jagori Chatterjee, Devender S Dhanda, Anirban Basu, David L Veenstra, Josh J Carlson
Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment. Personalized medicine 17 (5) (2020)
Deirdre Weymann, David L Veenstra, Anirban Basu, Josh J Carlson
Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study. PharmacoEconomics 38 (1) (2020)
Katherine Dixon, Sean Young, Yaoqing Shen, My Linh Thibodeau, Alexandra Fok, Erin Pleasance, Eric Zhao, Martin Jones, Geraldine Aubert, Linlea Armstrong, Alice Virani, Deirdre Weymann, Karen A Gelmon, Dan Renouf, Stephen Chia, Ian Bosdet, S Rod Rassekh, Rebecca J Deyell, Stephen Yip, Ana Fisic, Emma Titmuss, Shirin Abadi, Steven J M Jones, Sophie Sun, Aly Karsan, Marco A Marra, Janessa Laskin, Howard Lim, Kasmintan A Schrader
Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology. JNCI cancer spectrum 4 (5) (2020)
Erin Pleasance, Emma Titmuss, Laura Williamson, Harwood Kwan, Luka Culibrk, Eric Y Zhao, Katherine Dixon, Kevin Fan, Reanne Bowlby, Martin R Jones, Yaoqing Shen, Jasleen K Grewal, Jahanshah Ashkani, Kathleen Wee, Cameron J Grisdale, My Linh Thibodeau, Zoltan Bozoky, Hillary Pearson, Elisa Majounie, Tariq Vira, Reva Shenwai, Karen L Mungall, Eric Chuah, Anna Davies, Mya Warren, Caralyn Reisle, Melika Bonakdar, Gregory A Taylor, Veronika Csizmok, Simon K Chan, Zusheng Zong, Steve Bilobram, Amir Muhammadzadeh, Darryl D'Souza, Richard D Corbett, Daniel MacMillan, Marcus Carreira, Caleb Choo, Dustin Bleile, Sara Sadeghi, Wei Zhang, Tina Wong, Dean Cheng, Scott D Brown, Robert A Holt, Richard A Moore, Andrew J Mungall, Yongjun Zhao, Jessica Nelson, Alexandra Fok, Yussanne Ma, Michael K C Lee, Jean-Michel Lavoie, Shehara Mendis, Joanna M Karasinska, Balvir Deol, Ana Fisic, David F Schaeffer, Stephen Yip, Kasmintan Schrader, Deirdre Weymann, Deirdre Weymann, Stephen Chia, Karen Gelmon, Anna Tinker, Sophie Sun, Howard Lim, Daniel J Renouf, Janessa Laskin, Steven J M Jones, Marco A Marra
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes. Nature cancer 1 (4) (2020)
Samantha Pollard, Steve E Kalloger, Deirdre Weymann, Sophie Sun, Jennifer Nuk, Kasmintan A Schrader, Deirdre Weymann
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication. Health expectations : an international journal of public participation in health care and health policy 23 (4) (2020)
Deirdre Weymann, Nick Dragojlovic, Samantha Pollard, Deirdre Weymann
Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges. Journal of community genetics (2019)
Samantha Pollard, Sophie Sun, Deirdre Weymann
Balancing uncertainty with patient autonomy in precision medicine. Nature reviews. Genetics 20 (5) (2019)
Deirdre Weymann, Janessa Laskin, Robyn Roscoe, Kasmintan A Schrader, Stephen Chia, Stephen Yip, Winson Y Cheung, Karen A Gelmon, Aly Karsan, Daniel J Renouf, Marco Marra, Dean A Regier
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Molecular genetics & genomic medicine 5 (3) (2017)

Deirdre Weymann.css-eqlu8i{font-size:small;padding-left:4px;} (Dean Regier, Dean A Regier)

Publication Activity (10 Years)

Top Topics

Top Venues

Deirdre Weymann (Dean Regier, Dean A Regier)